ЕРЛОТИНІБ КРКА
Analogs of ЕРЛОТИНІБ КРКА
Find cheaper analogs and generic equivalents for ЕРЛОТИНІБ КРКА.
सक्रिय अवयव: Erlotinib
उत्पाद अवलोकन
About ЕРЛОТИНІБ КРКА
ЕРЛОТИНІБ КРКА is a prescription medication containing the active ingredient Erlotinib, a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations. It is also indicated for the treatment of pancreatic cancer.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
- Treatment of pancreatic cancer
Active Ingredient & Action
Erlotinib works by inhibiting the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and other related receptors, thereby blocking the signal transduction pathways that promote cancer cell growth and proliferation. This leads to a decrease in tumor size and an improvement in symptoms.
Important Notes
ЕРЛОТИНІБ КРКА should only be used under the guidance of a qualified healthcare professional. Patients should be monitored for signs of skin rash, diarrhea, and other adverse effects. Regular blood tests are necessary to check for liver and pancreatic enzyme elevations. Concomitant use with other medications may require dose adjustments or special precautions.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.